{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:55:20Z","timestamp":1791474920533,"version":"4.3.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atopic dermatitis (AD) and <jats:italic>psoriasis vulgaris<\/jats:italic> (PV) are chronic inflammatory skin diseases with heterogeneous molecular backgrounds. MicroRNAs (miRNAs) contribute to either development or regulation of many immune system related diseases. Only few miRNA profiling studies are available for AD and no comparisons between AD and PV skin miRNA profiles have been performed recently. We conducted a miRNA profiling analysis of skin, as well as serum, from adult AD and PV patients and control individuals. 130 miRNAs were differentially expressed in AD skin, of which 77 were common differentially expressed in AD and PV. No differentially expressed miRNAs were detected in serum. Pathway analyses revealed differentially expressed miRNAs to potentially target immune-system related pathways, including TNF-\u03b1, IL-2\/STAT4 and IL-6\/JAK\/STAT3. Additional genetic analysis of published AD GWAS dataset detected association of several target genes of differentially expressed miRNAs in skin. Moreover, miR-28-5p, miR-31-5p, miR-378a-3p and miR-203a were validated as upregulated in the skin of AD and PV patients. All validated miRNAs were reliable predictive markers for AD or PV. In conclusion, miRNA expression pattern in the skin of adult AD patients is highly similar to that of PV with multiple differentially expressed miRNAs potentially involved in the regulation of immune responses in AD and PV.<\/jats:p>","DOI":"10.1038\/s41598-022-27235-2","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T15:38:49Z","timestamp":1672501129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["miRNA expression profiles of the perilesional skin of atopic dermatitis and psoriasis patients are highly similar"],"prefix":"10.1038","volume":"12","author":[{"given":"Gemma","family":"Carreras-Badosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Maslovskaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Vaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pajusaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarmo","family":"Annilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"L\u00e4ttekivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"H\u00fcbenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Weidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fclli","family":"Kingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rebane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,31]]},"reference":[{"issue":"12","key":"27235_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S St\u00e4nder","year":"2021","unstructured":"St\u00e4nder, S. Atopic dermatitis. N. Engl. J. Med. 384(12), 1136\u20131143 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"27235_CR2","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jid.2019.08.437","volume":"139","author":"AC Billi","year":"2019","unstructured":"Billi, A. C., Gudjonsson, J. E. & Voorhees, J. J. Psoriasis: Past, present, and future. J. Investig. Dermatol. 139(11), e133\u2013e142 (2019).","journal-title":"J. Investig. Dermatol."},{"key":"27235_CR3","first-page":"1","volume":"1","author":"CA Akdis","year":"2021","unstructured":"Akdis, C. A. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?. Nat. Rev. Immunol. Nat. Res. 1, 1 (2021).","journal-title":"Nat. Rev. Immunol. Nat. Res."},{"issue":"10281","key":"27235_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. N. W. N. Psoriasis. The Lancet 397(10281), 1301\u20131315 (2021).","journal-title":"The Lancet"},{"issue":"12","key":"27235_CR5","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJMoa2019380","volume":"384","author":"T Bieber","year":"2021","unstructured":"Bieber, T. et al. Abrocitinib versus placebo or dupilumab for atopic dermatitis. N. Engl. J. Med. 384(12), 1101\u20131112 (2021).","journal-title":"N. Engl. J. Med."},{"key":"27235_CR6","first-page":"4","volume":"11","author":"M Nogueira","year":"2021","unstructured":"Nogueira, M. & Torres, T. Janus Kinase inhibitors for the treatment of atopic dermatitis: Focus on abrocitinib, baricitinib, and upadacitinib. Dermatol. Pract. Concept. 11, 4 (2021).","journal-title":"Dermatol. Pract. Concept."},{"issue":"10275","key":"27235_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi, K., Balato, A., Enerb\u00e4ck, C. & Sabat, R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. The Lancet 397(10275), 754\u2013766 (2021).","journal-title":"The Lancet"},{"issue":"5","key":"27235_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5021\/ad.22.003","volume":"34","author":"S Oh","year":"2022","unstructured":"Oh, S., Choi, S. & Yoon, H.-S. Available alternative biologics and disease groups influence biologic drug survival in patients with psoriasis and psoriatic arthritis. Ann. Dermatol. 34(5), 321 (2022).","journal-title":"Ann. Dermatol."},{"issue":"1","key":"27235_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jaci.2020.05.048","volume":"147","author":"H He","year":"2021","unstructured":"He, H. et al. Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis. J. Allergy Clin. Immunol. 147(1), 199\u2013212 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"13","key":"27235_CR10","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2340\/00015555-3337","volume":"99","author":"E Reimann","year":"2019","unstructured":"Reimann, E. et al. Multicomponent biomarker approach improves the accuracy of diagnostic biomarkers for psoriasis vulgaris. Acta Derm. Venereol. 99(13), 1258\u20131265 (2019).","journal-title":"Acta Derm. Venereol."},{"issue":"4","key":"27235_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1684\/ejd.2017.3024","volume":"27","author":"TG Ruksha","year":"2017","unstructured":"Ruksha, T. G., Komina, A. V. & Palkina, N. V. MicroRNA in skin diseases. Eur. J. Dermatol. 27(4), 343\u2013352 (2017).","journal-title":"Eur. J. Dermatol."},{"issue":"11","key":"27235_CR12","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1111\/jcmm.15208","volume":"24","author":"X Yu","year":"2020","unstructured":"Yu, X. et al. MicroRNAs in atopic dermatitis: A systematic review. J. Cell. Mol. Med. 24(11), 5966\u20135972 (2020).","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"27235_CR13","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/all.14646","volume":"76","author":"J Weidner","year":"2021","unstructured":"Weidner, J. et al. Spotlight on microRNAs in allergy and asthma. Allergy 76(6), 1661\u20131678 (2021).","journal-title":"Allergy"},{"key":"27235_CR14","first-page":"1","volume":"1","author":"\u00c5 Solvin","year":"2021","unstructured":"Solvin, \u00c5. et al. MicroRNA profiling of psoriatic skin identifies 11 miRNAs associated with disease severity. Exp. Dermatol. 1, 1 (2021).","journal-title":"Exp. Dermatol."},{"issue":"1","key":"27235_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jdermsci.2019.11.003","volume":"97","author":"D Deli\u0107","year":"2020","unstructured":"Deli\u0107, D. et al. Integrated microRNA\/mRNA expression profiling of the skin of psoriasis patients. J. Dermatol. Sci. 97(1), 9\u201320 (2020).","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"27235_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/exd.12604","volume":"24","author":"MB L\u00f8vendorf","year":"2015","unstructured":"L\u00f8vendorf, M. B. et al. Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis. Exp. Dermatol. 24(3), 187\u2013193 (2015).","journal-title":"Exp. Dermatol."},{"key":"27235_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1371\/journal.pone.0000610","volume":"2","author":"E Sonkoly","year":"2007","unstructured":"Sonkoly, E. et al. MicroRNAs: Novel regulators involved in the pathogenesis of psoriasis?. PLoS ONE 2, 7 (2007).","journal-title":"PLoS ONE"},{"key":"27235_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms8652","volume":"6","author":"S Yan","year":"2015","unstructured":"Yan, S. et al. NF-\u03baB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nat. Commun. 6, 1 (2015).","journal-title":"Nat. Commun."},{"issue":"9","key":"27235_CR19","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jid.2017.05.012","volume":"137","author":"H Hermann","year":"2017","unstructured":"Hermann, H. et al. miR-146b probably assists miRNA-146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis. J. Invest. Dermatol. 137(9), 1945\u20131954 (2017).","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"27235_CR20","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jaci.2014.05.022","volume":"134","author":"A Rebane","year":"2014","unstructured":"Rebane, A. et al. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J. Allergy Clin. Immunol. 134(4), 836-847.e11 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"27235_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cca.2021.01.008","volume":"516","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Circulating microRNAs: Biomarkers of disease. Clin. Chim. Acta 516, 46\u201354 (2021).","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"27235_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115448","volume":"9","author":"Y Lv","year":"2014","unstructured":"Lv, Y. et al. Profiling of serum and urinary MicroRNAs in children with atopic dermatitis. PLoS ONE 9(12), e115448 (2014).","journal-title":"PLoS ONE"},{"issue":"12","key":"27235_CR23","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1111\/all.13579","volume":"73","author":"G Carreras-Badosa","year":"2018","unstructured":"Carreras-Badosa, G. et al. microRNA-146a is linked to the production of IgE in mice but not in atopic dermatitis patients. Allergy Eur. J. Allergy Clin. Immunol. 73(12), 2400\u20132403 (2018).","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"issue":"1","key":"27235_CR24","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1080\/21655979.2021.1925205","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris. Bioengineered 12(1), 1838\u20131850 (2021).","journal-title":"Bioengineered"},{"key":"27235_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells9122656","volume":"9","author":"S Domingo","year":"2020","unstructured":"Domingo, S., Sol\u00e9, C., Molin\u00e9, T., Ferrer, B. & Cort\u00e9s-Hern\u00e1ndez, J. MicroRNAs in several cutaneous autoimmune diseases: Psoriasis, cutaneous lupus erythematosus and atopic dermatitis. Cells 9, 12 (2020).","journal-title":"Cells"},{"issue":"5","key":"27235_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000515114","volume":"34","author":"Z Meng","year":"2021","unstructured":"Meng, Z., Qiu, J. & Zhang, H. MiR-221-3p as a potential biomarker for patients with psoriasis and its role in inflammatory responses in keratinocytes. Skin Pharmacol. Physiol. 34(5), 300\u2013306 (2021).","journal-title":"Skin Pharmacol. Physiol."},{"issue":"12","key":"27235_CR27","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/ng.3424","volume":"47","author":"L Paternoster","year":"2015","unstructured":"Paternoster, L. et al. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat. Genet. 47(12), 1449\u20131456 (2015).","journal-title":"Nat. Genet."},{"key":"27235_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2021.646796","volume":"8","author":"Y Xiuli","year":"2021","unstructured":"Xiuli, Y. & Honglin, W. miRNAs flowing up and down: The concerto of psoriasis. Front. Med. 8, 1 (2021).","journal-title":"Front. Med."},{"key":"27235_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-93616-8","volume":"11","author":"W Soonthornchai","year":"2021","unstructured":"Soonthornchai, W. et al. MicroRNA-378a-3p is overexpressed in psoriasis and modulates cell cycle arrest in keratinocytes via targeting BMP2 gene. Sci. Rep. 11, 1 (2021).","journal-title":"Sci. Rep."},{"issue":"22","key":"27235_CR30","first-page":"11801","volume":"24","author":"J Freire De Carvalho","year":"2020","unstructured":"Freire De Carvalho, J. & Machado Ribeiro, F. The potential role of microRNAs as biomarkers in atopic dermatitis: A systematic review. Eur. Rev. Med. Pharmacol. Sci. 24(22), 11801\u201311803 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"27235_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jaci.2016.07.025","volume":"139","author":"A Srivastava","year":"2017","unstructured":"Srivastava, A. et al. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis. J. Allergy Clin. Immunol. 139(2), 550\u2013561 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"27235_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jdermsci.2014.05.005","volume":"75","author":"MB L\u00f8vendorf","year":"2014","unstructured":"L\u00f8vendorf, M. B., Zibert, J. R., Gyldenl\u00f8ve, M., R\u00f8pke, M. A. & Skov, L. MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis. J. Dermatol. Sci. 75(2), 133\u2013139 (2014).","journal-title":"J. Dermatol. Sci."},{"issue":"5","key":"27235_CR33","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaci.2011.01.053","volume":"127","author":"E Guttman-Yassky","year":"2011","unstructured":"Guttman-Yassky, E., Nograles, K. E. & Krueger, J. G. Contrasting pathogenesis of atopic dermatitis and psoriasis\u2013part I: Clinical and pathologic concepts. J. Allergy Clin. Immunol. 127(5), 1110\u20131118 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"27235_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","volume":"48","author":"E Guttman-Yassky","year":"2017","unstructured":"Guttman-Yassky, E. & Krueger, J. G. Atopic dermatitis and psoriasis: Two different immune diseases or one spectrum?. Curr. Opin. Immunol. 48, 68\u201373 (2017).","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"27235_CR35","first-page":"38","volume":"84","author":"D Engler","year":"2017","unstructured":"Engler, D., Chezuba, H. P. & Masuku, P. Psoriasis. SA Pharmaceut. J. 84(5), 38\u201342 (2017).","journal-title":"SA Pharmaceut. J."},{"key":"27235_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7527859","volume":"1","author":"A Bozek","year":"2020","unstructured":"Bozek, A., Zajac, M. & Krupka, M. Atopic dermatitis and psoriasis as overlapping syndromes. Mediat. Inflamm. 1, 1 (2020).","journal-title":"Mediat. Inflamm."},{"key":"27235_CR37","first-page":"55","volume":"71","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Rosmarinic acid protects mice from imiquimod induced psoriasis-like skin lesions by inhibiting the IL-23\/Th17 axis via regulating Jak2\/Stat3 signaling pathway. Phyther. Res. 71, 55 (2021).","journal-title":"Phyther. Res."},{"key":"27235_CR38","unstructured":"Du, Y., Jiang, S, & Cheng, L. JAK\/STAT and VEGF\/PAK1 signaling as emerging targets for topical treatment of psoriasis: A pilot study. Int. J. Clin. Exp. Pathol. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/33425111\/. Accessed: 26-May-2021."},{"issue":"11","key":"27235_CR39","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.3390\/jcm9113741","volume":"9","author":"M Furue","year":"2020","unstructured":"Furue, M. Regulation of skin barrier function via competition between AHR Axis versus IL-13\/IL-4-JAK-STAT6\/STAT3 Axis: Pathogenic and therapeutic implications in atopic dermatitis. J. Clin. Med. 9(11), 3741 (2020).","journal-title":"J. Clin. Med."},{"key":"27235_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.652846","volume":"12","author":"P Martin","year":"2021","unstructured":"Martin, P., Goldstein, J. D., Mermoud, L., Diaz-Barreiro, A. & Palmer, G. IL-1 family antagonists in mouse and human skin inflammation. Front. Immunol. 12, 1 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"27235_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/all.13954","volume":"75","author":"T Bieber","year":"2020","unstructured":"Bieber, T. Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis. Allergy 75(1), 54\u201362 (2020).","journal-title":"Allergy"},{"key":"27235_CR42","doi-asserted-by":"crossref","unstructured":"Domingo, S., Sol\u00e9, C., Molin\u00e9, T., Ferrer, B., & Cort\u00e9s-Hern\u00e1ndez, J. Cells MicroRNAs in several cutaneous autoimmune diseases: Psoriasis, cutaneous lupus erythematosus and atopic dermatitis (2020).","DOI":"10.3390\/cells9122656"},{"issue":"1","key":"27235_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4049\/jimmunol.1701133","volume":"200","author":"SS Majri","year":"2018","unstructured":"Majri, S. S. et al. STAT5B: A differential regulator of the life and death of CD4 + effector memory T cells. J. Immunol. 200(1), 110\u2013118 (2018).","journal-title":"J. Immunol."},{"issue":"2","key":"27235_CR44","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2013.12.029","volume":"6","author":"T Ando","year":"2014","unstructured":"Ando, T. et al. Critical role for mast cell Stat5 activity in skin inflammation. Cell Rep. 6(2), 366\u2013376 (2014).","journal-title":"Cell Rep."},{"key":"27235_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1126\/sciimmunol.aav1080","volume":"5","author":"D Bauch\u00e9","year":"2020","unstructured":"Bauch\u00e9, D. et al. IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis. Sci. Immunol. 5, 46 (2020).","journal-title":"Sci. Immunol."},{"key":"27235_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2012.00234","volume":"3","author":"T Kanai","year":"2012","unstructured":"Kanai, T., Jenks, J. & Nadeau, K. C. The STAT5b pathway defect and autoimmunity. Front. Immunol. 3, 1 (2012).","journal-title":"Front. Immunol."},{"key":"27235_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms19061665","volume":"19","author":"AD Truong","year":"2018","unstructured":"Truong, A. D. et al. Interleukin-34 regulates Th1 and Th17 cytokine production by activating multiple signaling pathways through CSF-1R in chicken cell lines. Int. J. Mol. Sci. 19, 6 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"27235_CR48","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1093\/hmg\/ddr331","volume":"20","author":"CE Joyce","year":"2011","unstructured":"Joyce, C. E. et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum. Mol. Genet. 20(20), 4025\u20134040 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"27235_CR49","unstructured":"Xia, P., et al., miR-378a regulates keratinocyte responsiveness to IL-17A in psoriasis. Br. J. Dermatol. (2022)."},{"key":"27235_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02449","volume":"10","author":"K Dubois-Camacho","year":"2019","unstructured":"Dubois-Camacho, K. et al. Inhibition of miR-378a-3p by inflammation enhances IL-33 levels: A novel mechanism of alarmin modulation in ulcerative colitis. Front. Immunol. 10, 1 (2019).","journal-title":"Front. Immunol."},{"issue":"4","key":"27235_CR51","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jaci.2020.09.023","volume":"147","author":"A Al Kindi","year":"2021","unstructured":"Al Kindi, A. et al. Staphylococcus aureus second immunoglobulin-binding protein drives atopic dermatitis via IL-33. J. Allergy Clin. Immunol. 147(4), 1354\u20131368 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"27235_CR52","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/09168451.2019.1694860","volume":"84","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Zheng, Y. & Zhu, G. MiR-203a-3p targets PTEN to promote hepatocyte proliferation by regulating PI3K\/Akt pathway in BRL-3A cells. Biosci. Biotechnol. Biochem. 84(4), 725\u2013733 (2020).","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"4","key":"27235_CR53","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ptr.6283","volume":"33","author":"H Wang","year":"2019","unstructured":"Wang, H. & Wei, S. Tanshinol relieves lipopolysaccharide-induced inflammatory injury of HaCaT cells via down-regulation of microRNA-122. Phyther. Res. 33(4), 910\u2013918 (2019).","journal-title":"Phyther. Res."},{"key":"27235_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.imlet.2020.06.015","volume":"226","author":"KH Hsu","year":"2020","unstructured":"Hsu, K. H. et al. Upregulation of RelB in the miR-122 knockout mice contributes to increased levels of proinflammatory chemokines\/cytokines in the liver and macrophages. Immunol. Lett. 226, 22\u201330 (2020).","journal-title":"Immunol. Lett."},{"key":"27235_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2019.111738","volume":"387","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z. et al. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122\u20135p. Exp. Cell Res. 387, 1 (2020).","journal-title":"Exp. Cell Res."},{"issue":"2","key":"27235_CR56","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jaad.2015.09.062","volume":"74","author":"M Futamura","year":"2016","unstructured":"Futamura, M. et al. A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standards. J. Am. Acad. Dermatol. 74(2), 288\u2013294 (2016).","journal-title":"J. Am. Acad. Dermatol."},{"key":"27235_CR57","first-page":"14","volume":"33","author":"V Oji","year":"2015","unstructured":"Oji, V. & Luger, T. A. The skin in psoriasis: Assessment and challenges. Clin. Exp. Rheumatol. 33, 14\u201319 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"W1","key":"27235_CR58","doi-asserted-by":"publisher","first-page":"W566","DOI":"10.1093\/nar\/gkv468","volume":"43","author":"T Metsalu","year":"2015","unstructured":"Metsalu, T. & Vilo, J. ClustVis: A web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 43(W1), W566\u2013W570 (2015).","journal-title":"Nucleic Acids Res."},{"key":"27235_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, 1 (2015).","journal-title":"Elife"},{"issue":"W1","key":"27235_CR60","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44(W1), W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"27235_CR61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1(6), 417\u2013425 (2015).","journal-title":"Cell Syst."},{"issue":"6","key":"27235_CR62","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The genotype-tissue expression (GTEx) project. Nat. Genet. 45(6), 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"issue":"7502","key":"27235_CR63","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature13302","volume":"509","author":"MS Kim","year":"2014","unstructured":"Kim, M. S. et al. A draft map of the human proteome. Nature 509(7502), 575\u2013581 (2014).","journal-title":"Nature"},{"issue":"7","key":"27235_CR64","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/nar\/gkz097","volume":"47","author":"J Alles","year":"2019","unstructured":"Alles, J. et al. An estimate of the total number of true human miRNAs. Nucleic Acids Res. 47(7), 3353\u20133364 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27235-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27235-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27235-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T16:04:43Z","timestamp":1672502683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27235-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27235"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-27235-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,31]]},"assertion":[{"value":"25 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22645"}}